Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 14 results found. Search for [ Lawsuit Against Indian Pharma Companies ]

Results 1 to 14 of 14
BusinessToday.In
New Delhi, May 15, 2019
After Cognizant, IBM India fires 300 employees from services divisionTech behemoth IBM India has reportedly fired nearly 300 employees from its services division as it looks to \"re-invent\" its operations and fulfill the changing demand of the customers. The US-based IT major let these employees go as it focuses on emerging technology like Artificial Intelligence and reduces exposure to traditional services. US pharma scandal: Indian firm Glenmark may face a penalty of up to $873 millio...


BusinessToday.In
May 15, 2019
Share Market Updates: Shedding gains of the trading session Wednesday, benchmark indices closed in the red. Other major indices gave up all intraday gains to turn negative in trade as well.


PTI
May 14, 2019
In separate clarifications to stock exchanges, the companies denied the accusations and stated they would defend themselves in the matter


PTI
May 14, 2019



Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 14, 2019
Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.


Gina Krishnan
New Delhi, February 6, 2018
With the Delhi High Court's verdict, Daiichi Sankyo has scored a victory against former Ranbaxy promoters. But it won't end there.


E Kumar Sharma
New Delhi, November 12, 2017
Every business has the right to adopt legitimate practises to protect their own interest. Right? But a recent article argues that going beyond the patent act, which permits research and development during the life of a patent, some innovator drug companies are busy trying to block this.


E Kumar Sharma
November 3, 2017
The list includes names of some of India's leading pharmaceutical companies like Sun Pharma, Dr Reddy's, Glenmark and Aurobindo.


E Kumar Sharma
June 27, 2016
The product is used for the treatment of Metastatic Colorectal Cancer (mCRC). Swiss healthcare giant Roche has filed a lawsuit in the Delhi High Court to prevent the launch of Bevacizumab in India but Hetero Drugs said that there no order against the company.


E. Kumar Sharma
June 13, 2013
The stock dropped more than six per cent in early trade to touch Rs 916 compared with Wednesday's close of Rs 981. It later partly recovered to trade at Rs 952 around noon.


E. Kumar Sharma
March 27, 2012
Compulsory licences have brought domestic and multinational pharma companies face to face. Although domestic firms are getting to make cheaper versions of patented drugs, will this be enough to cure the country of its health care ills?


Shamni Pande
March 5, 2009
In businesses, big or small, ranging from manufacturing to music, the fight for intellectual property is getting intense. Neglect it and you could be out of business.


PAGES 1 OF 1